MRSA Screening May Not Cut Infection Rate
Posted on: Wednesday, 12 March 2008, 00:00 CDT
Hospital admission screening for methicillin-resistant Staphylococcus aureus does not appear to reduce hospital-acquired infections, a Swiss study found.
Dr.Stephan Harbarth and colleagues with the University of Geneva Hospitals and Medical School in Switzerland conducted a study to evaluate the effect of an early detection strategy on MRSA infections acquired in a hospital among 21,754 surgical patients at a Swiss teaching hospital.
Twelve surgical wards were assigned to either the control group or intervention group for a nine-month period. Then they switched to the other group for another nine months.
Admission screening during the intervention periods identified a total of 515 MRSA-positive patients.
The study, published in the Journal in American Medical Association, a total of 93 patients developed hospital-acquired MRSA in the intervention periods compared with 76 patients in the control periods.
Overall, the trial did not show an added benefit for widespread rapid screening on admission compared with standard MRSA control alone.
Source: United Press International
Related Articles
- Oncolytics Biotech Inc. Treats 200th Cancer Patient in Clinical Studies With REOLYSIN(R)
- Analysis Showed No Increased Risk of Hospitalization in Patients When Adding a LABA to ICS Compared to ICS Alone
- Anika Enrolls First Patient in Monovisc Study
- Semafore and Multiple Myeloma Research Consortium (MMRC) Dose First Patient in Phase I Study of Targeted PI3 Kinase (PI3K) Inhibitor
- St. Paul Heart Clinic Seeks Heart Failure Patients for Investigational Study Evaluating Use of New Implantable Pulse Generator
- Sinai Hospital of Baltimore Acquires Second CyberKnife(R) System to Support Rapid Growth in Extracranial Tumor Treatments
- St. Francis Hospital Seeks Heart Failure Patients for Investigational Study Evaluating Use of New Implantable Pulse Generator
- Newark Beth Israel Medical Center Seeks Heart Failure Patients for Investigational Study Evaluating Use of New Implantable Pulse Generator
- Infections of Febrile Neutropenic Patients in Malignant Hematological Diseases (Second Study Period)
- California Pacific Medical Center Seeks Heart Failure Patients for Investigational Study Evaluating Use of New Implantable Pulse Generator
 |
 |
User Comments (0)
RSS Feeds